These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17891583)

  • 21. Influence of the lactose grade within dry powder formulations of fluticasone propionate and terbutaline sulphate.
    Le VN; Bierend H; Robins E; Steckel H; Flament MP
    Int J Pharm; 2012 Jan; 422(1-2):75-82. PubMed ID: 22036653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of crystallinity on electrostatic charging in dry powder inhaler formulations.
    Wong J; Kwok PC; Noakes T; Fathi A; Dehghani F; Chan HK
    Pharm Res; 2014 Jul; 31(7):1656-64. PubMed ID: 24464269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dry powder inhaler: influence of humidity on topology and adhesion studied by AFM.
    Bérard V; Lesniewska E; Andrès C; Pertuy D; Laroche C; Pourcelot Y
    Int J Pharm; 2002 Jan; 232(1-2):213-24. PubMed ID: 11790505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modification of electrostatic charge on inhaled carrier lactose particles by addition of fine particles.
    Bennett FS; Carter PA; Rowley G; Dandiker Y
    Drug Dev Ind Pharm; 1999 Jan; 25(1):99-103. PubMed ID: 10028425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Powder specific active dispersion for generation of pharmaceutical aerosols.
    Crowder T; Hickey A
    Int J Pharm; 2006 Dec; 327(1-2):65-72. PubMed ID: 16930884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of crystal form of ipratropium bromide on micronisation and aerosolisation behaviour in dry powder inhaler formulations.
    Shur J; Kubavat HA; Ruecroft G; Hipkiss D; Price R
    J Pharm Pharmacol; 2012 Sep; 64(9):1326-36. PubMed ID: 22881444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of triboelectric charging in dry powder inhalers using electrical low pressure impactor (ELPI).
    Telko MJ; Kujanpää J; Hickey AJ
    Int J Pharm; 2007 May; 336(2):352-60. PubMed ID: 17218072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation pre-screening of inhalation powders using computational atom-atom systematic search method.
    Ramachandran V; Murnane D; Hammond RB; Pickering J; Roberts KJ; Soufian M; Forbes B; Jaffari S; Martin GP; Collins E; Pencheva K
    Mol Pharm; 2015 Jan; 12(1):18-33. PubMed ID: 25380027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of Formulation and Device Factors Determine the In Vitro Performance of Salbutamol Sulphate Dry Powders for Inhalation.
    Muddle J; Murnane D; Parisini I; Brown M; Page C; Forbes B
    J Pharm Sci; 2015 Nov; 104(11):3861-3869. PubMed ID: 26220184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Granulated Lactose as a Carrier for Dry Powder Inhaler Formulations 2: Effect of Drugs and Drug Loading.
    Du P; Du J; Smyth HDC
    J Pharm Sci; 2017 Jan; 106(1):366-376. PubMed ID: 27939234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adhesion forces in interactive mixtures for dry powder inhalers--evaluation of a new measuring method.
    Lohrmann M; Kappl M; Butt HJ; Urbanetz NA; Lippold BC
    Eur J Pharm Biopharm; 2007 Sep; 67(2):579-86. PubMed ID: 17418548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Effect of Active Pharmaceutical Ingredients on Aerosol Electrostatic Charges from Pressurized Metered Dose Inhalers.
    Chen Y; Young PM; Fletcher DF; Chan HK; Long E; Lewis D; Church T; Traini D
    Pharm Res; 2015 Sep; 32(9):2928-36. PubMed ID: 25788449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of particle morphology on the triboelectrification in dry powder inhalers.
    Murtomaa M; Mellin V; Harjunen P; Lankinen T; Laine E; Lehto VP
    Int J Pharm; 2004 Sep; 282(1-2):107-14. PubMed ID: 15336386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
    Kaialy W; Ticehurst M; Nokhodchi A
    Int J Pharm; 2012 Feb; 423(2):184-94. PubMed ID: 22197772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Influence of Relative Humidity and Storage Conditions on the Physico-chemical Properties of Inhalation Grade Fine Lactose.
    Stankovic-Brandl M; Zellnitz S; Wirnsberger P; Kobler M; Paudel A
    AAPS PharmSciTech; 2021 Nov; 23(1):1. PubMed ID: 34791545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of separation characteristics between salbutamol sulfate (SS) particles and model carrier excipients on dry powder for inhalation].
    Iida K; Leuenberger H; Fueg LM; Müller-Walz R; Danjo K
    Yakugaku Zasshi; 1999 Oct; 119(10):752-62. PubMed ID: 10518459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of surface processing of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate.
    Iida K; Inagaki Y; Todo H; Okamoto H; Danjo K; Luenberger H
    Chem Pharm Bull (Tokyo); 2004 Aug; 52(8):938-42. PubMed ID: 15304985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of Salbutamol Delivered from the Unit Dose Dry Powder Inhaler: Comparison with the Metered Dose Inhaler and Diskus Dry Powder Inhaler.
    Moore A; Riddell K; Joshi S; Chan R; Mehta R
    J Aerosol Med Pulm Drug Deliv; 2017 Jun; 30(3):164-172. PubMed ID: 28170282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Applicability of Bipolar Charge Analyzer (BOLAR) in Characterizing the Bipolar Electrostatic Charge Profile of Commercial Metered Dose Inhalers (MDIs).
    Leung SS; Chiow AC; Ukkonen A; Chan HK
    Pharm Res; 2016 Feb; 33(2):283-91. PubMed ID: 26337773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of contamination of pharmaceutical equipment on powder triboelectrification.
    Eilbeck J; Rowley G; Carter PA; Fletcher EJ
    Int J Pharm; 2000 Feb; 195(1-2):7-11. PubMed ID: 10675675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.